← 返回

核因子 E2 相关因子 2 负向调控去势抵抗性前列腺癌细胞中多西他赛诱导的铁死亡

英文原题:Nuclear Factor Erythroid 2-Related Factor 2 Negatively Regulates Docetaxel-Induced Ferroptosis in Castration-Resistant Prostate Cancer Cells.

查看英文原题

Nuclear Factor Erythroid 2-Related Factor 2 Negatively Regulates Docetaxel-Induced Ferroptosis in Castration-Resistant Prostate Cancer Cells.

PubMed 2026/04/03(内容时间) World J Mens Health Q1 · IF 4.3(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

DTX 在 CRPC 细胞中诱导铁死亡,该过程受 NRF2 负调控。DTX 联合 TFRC-CAR-T 细胞对 CRPC 细胞具有更强的杀伤作用,并增加细胞因子分泌。

研究思路结论见上方概要

我们探讨了多西他赛(DTX)是否在去势抵抗性前列腺癌(CRPC)细胞中诱导铁死亡,并进一步研究了其作用机制及其对肿瘤免疫微环境的调控。

首先,通过DTX诱导的CRPC细胞形态、代谢及蛋白表达特征性变化以及电子显微镜超微结构,验证了铁死亡的发生。随后,通过转录组测序和基因集富集分析,根据差异表达基因及其关键信号通路筛选出核因子E2相关因子2(NRF2)基因。沉默NRF2(si-NRF2)以探讨其对DTX诱导的CRPC细胞铁死亡的调控机制。最后,构建TFRC-CAR-T 细胞联合DTX,探讨其抗肿瘤能力及免疫调节作用。

CRPC细胞活力随DTX浓度增加而下降,且这一下降趋势可被铁死亡抑制剂(ferrostatin-1)部分逆转。DTX诱导的CRPC细胞中,细胞内脂质活性氧和丙二醛水平显著升高,而谷胱甘肽水平和谷胱甘肽过氧化物酶活性显著降低。透射电子显微镜显示线粒体明显收缩、球形重塑和膜致密化。转录组测序和基因集富集分析揭示,抗氧化应激通路中的NRF2基因主要参与调控铁死亡。免疫组化和细胞学Western Blot显示,DTX化疗激活NRF2,同时上调CRPC细胞中的转铁蛋白受体(TFRC)。si-NRF2基因增强DTX诱导的CRPC细胞铁死亡敏感性。单独使用TFRC-CAR-T 细胞对CRPC细胞的杀伤作用较弱,而DTX联合TFRC-CAR-T 细胞相比单独DTX显示出更强的杀伤能力和增强的细胞因子分泌。

展开英文摘要原文

We explored whether docetaxel (DTX) induced ferroptosis in castration-resistant prostate cancer (CRPC) cells and further investigated its mechanism of action and its regulation of the tumor immune microenvironment.

First, DTX-induced characteristic changes in the morphology, metabolism and protein expression of CRPC cells as well as electron microscopy ultrastructure were used to verify the occurrence of ferroptosis. Then, through transcriptome sequencing and gene set enrichment analysis, the nuclear factor erythroid 2-related factor 2 ( NRF2 ) gene was screened out according to the differentially expressed genes and their key signaling pathways. Silencing NRF2 (si-NRF2) to explore its regulatory mechanism on DTX-induced ferroptosis in CRPC cells. Finally, TFRC-CAR-T cells combined with DTX were constructed to explore their antitumour ability and immune regulation.

The cell viability of CRPC cells decreased with increasing DTX concentration, and this downwards trend could be partially rescued by ferroptosis inhibitor (ferrostatin-1). Intracellular lipid reactive oxygen species and malondialdehyde levels were significantly increased in DTX-induced CRPC cells, while the levels of glutathione and glutathione peroxidase activity were significantly decreased. Transmission electron microscopy reveals marked mitochondrial shrinkage, spheroidal remodeling, and membrane densification. Transcriptome sequencing and gene set enrichment analysis revealed that the NRF2 gene in the antioxidant stress pathway is primarily involved in regulating ferroptosis. Immunohistochemistry and cytological Western Blot showed DTX chemotherapy activates NRF2 while also up-regulating transferrin receptor (TFRC) in CRPC cells. si- NRF2 gene enhance the sensitivity of DTX-induced ferroptosis in CRPC cells. The killing effect of TFRC-CAR-T cells alone on CRPC cells was weak, while DTX combined with TFRC-CAR-T cells demonstrated stronger killing ability and enhanced cytokine secretion compared to DTX alone.

DTX induces ferroptosis in CRPC cells, a process negatively regulated by NRF2. DTX combined with TFRC-CAR-T cells had a stronger lethal effect to CRPC cells and increase cytokine secretion.

论文信息

作者
Ke C、Gan J、Guo Z、Cui K、Tian J、Liu Z、Lei P、Hu Z
第一作者单位
Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.China
通讯作者单位
Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. cgyang-hust@hotmail.com.China
期刊
The world journal of men's health2026 Apr 3
原文标识
PubMed 42093253 · DOI 10.5534/wjmh.250299